SummaryThe analgesic eflects of transdermally applied 10% lignocaine ayuagel containing 3% glycyrrhetinic acid monohemiphthalute disodium (as an absorption enhancer) and EMLA cream were compared on the forearms of 34 adult volunteers in a double-blind jushion. The mean pinprick pain scores (graded by noting the number of painful pinpricks out of$ve) at 30,60 and 90 min ajier application and 30 rnin after removal of the anaesthetics were 3.3 (0.3) (mean S E ) , 1.2 (0.3), 0.3 (0.1) and 0.3 (0.1) respectively, in the lignocaine gel group. Corresponding scores were 3.5 (0.3). 1.5 (0.3), 0.7 (0.2) and 0.1 (0.1) respectively, in the EMLA group. Insertion of a 26-gauge needle into the treated skin to a depth of I rnm at 90 rnin after application was not painful in 91% of the volunteers in the lignocaine gel group and 88% of those in the EMLA group. There was no significunt diflerence in any of (he corresponding pain scores between the two groups.
Key wordsAnaesthetics, local; lignocaine, prilocaine, EMLA.We have developed a transdermally applicable 10% lignocaine gel mixture with 3% glycyrrhetinic acid monohemiphthalate disodium (GA MHPh 2Na) as an absorption promoter [I]. The effect of 3% GA MHPh 2Na as a promoter was confirmed in a double-blind human study [2]. Venous cannulation was carried out without pain in 65.5% of the adult patients and 82.4% of children after about 60 min of application [3]. Skin pretreatments, such as stripping with gum tape or cleaning with benzene, significantly shortened the latency time of the dermal patch anaesthesia [4]. EMLA (eutectic mixture of local anaesthetics) cream was developed in the 1980s in Europe [5] and is widely used prior to venepuncture [6,7], but is not yet commercially available in Japan.In the present study, the effects of 3% GA MHPh 2Na in 10% lignocaine gel (Lido-Gel) were compared with those of EMLA cream in a randomised, double-blind fashion.
MethodWith approval from the Institutional Ethics Committee on Human Research, we studied 34 healthy adult volunteers (31 males and three females, median age 29 years, range 22-47). Informed consent was obtained from all subjects.An independent controller prepared two round sponges, with a diameter of 25 mm and a thickness of 4 mm, into which approximately 0.3 g of either Lido-Gel or EMLA cream was soaked. These two sponges were randomly applied to the volar surface of the left or the right forearm by an anaesthetist, who was unaware of the contents of the sponges. The sponges were covered with a transparent occlusive dressing (Tegaderm R, 3M Corp.) for YO min. An